Follow
Karl R Gibson
Karl R Gibson
Sandexis Medicinal Chemistry Ltd
Verified email at sandexis.co.uk - Homepage
Title
Cited by
Cited by
Year
Remote, 1, 5-Anti stereoinduction in the boron-mediated aldol reactions of β-oxygenated methyl ketones
I Paterson, KR Gibson, RM Oballa
Tetrahedron letters 37 (47), 8585-8588, 1996
2501996
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform
B Desai, K Dixon, E Farrant, Q Feng, KR Gibson, WP van Hoorn, J Mills, ...
Journal of medicinal chemistry 56 (7), 3033-3047, 2013
1652013
Stereocontrolled Total Synthesis of (+)‐Altohyrtin A/Spongistatin 1
I Paterson, DYK Chen, MJ Coster, JL Aceņa, J Bach, KR Gibson, ...
Angewandte Chemie International Edition 40 (21), 4055-4060, 2001
1492001
Metabolism, pharmacokinetics and toxicity of functional groups: impact of chemical building blocks on ADMET
DA Smith
Royal Society of Chemistry, 2010
123*2010
Studies in marine macrolide synthesis: Synthesis of a C16 C28 subunit of spongistatin 1 (altohyrtin A) incorporating the CD-spiroacetal moiety
I Paterson, DJ Wallace, KR Gibson
Tetrahedron letters 38 (51), 8911-8914, 1997
1011997
The discovery of a potent, selective, and peripherally restricted pan-Trk inhibitor (PF-06273340) for the treatment of pain
SE Skerratt, M Andrews, SK Bagal, J Bilsland, D Brown, PJ Bungay, ...
Journal of Medicinal Chemistry 59 (22), 10084-10099, 2016
802016
Novel amino-pyrazole ureas with potent in vitro and in vivo antileishmanial activity
CE Mowbray, S Braillard, W Speed, PA Glossop, GA Whitlock, KR Gibson, ...
Journal of medicinal chemistry 58 (24), 9615-9624, 2015
762015
The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the CD-spiroacetal segment
I Paterson, MJ Coster, DYK Chen, KR Gibson, DJ Wallace
Organic & Biomolecular Chemistry 3 (13), 2410-2419, 2005
662005
Quantitative chemical proteomic profiling of ubiquitin specific proteases in intact cancer cells
JA Ward, L McLellan, M Stockley, KR Gibson, GA Whitlock, C Knights, ...
ACS chemical biology 11 (12), 3268-3272, 2016
612016
Total Synthesis of cis-Sylvaticin
LJ Brown, IB Spurr, SC Kemp, NP Camp, KR Gibson, RCD Brown
Organic Letters 10 (12), 2489-2492, 2008
522008
Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain
SK Bagal, PJ Bungay, SM Denton, KR Gibson, MS Glossop, TL Hay, ...
ACS medicinal chemistry letters 6 (6), 650-654, 2015
492015
Synthesis and conformational dynamics of tricyclic pyridones containing a fused seven-membered ring
KR Gibson, L Hitzel, RJ Mortishire-Smith, U Gerhard, RA Jelley, AJ Reeve, ...
The Journal of Organic Chemistry 67 (26), 9354-9360, 2002
442002
Design and Identification of a Novel, Functionally Subtype Selective GABAA Positive Allosteric Modulator (PF-06372865)
RM Owen, D Blakemore, L Cao, N Flanagan, R Fish, KR Gibson, ...
Journal of Medicinal Chemistry 62 (12), 5773-5796, 2019
392019
2-PYRIDINE CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL MODULATORS
S BAGAL, K GIBSON, M KEMP, C POINSARD, B STAMMEN, S DENTON, ...
WO Patent 2,008,135,826, 2008
34*2008
Preclinical and clinical pharmacokinetics of PF-02413873, a nonsteroidal progesterone receptor antagonist
PJ Bungay, S Tweedy, DC Howe, KR Gibson, HM Jones, NM Mount
Drug metabolism and disposition 39 (8), 1396-1405, 2011
282011
Tricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands
J Crawforth, JR Atack, SM Cook, KR Gibson, A Nadin, AP Owens, A Pike, ...
Bioorganic & medicinal chemistry letters 14 (7), 1679-1682, 2004
252004
Discovery and development of ASK1 inhibitors
R Brys, K Gibson, T Poljak, S Van Der Plas, D Amantini
Progress in Medicinal Chemistry 59, 101-179, 2020
222020
3-Substituted gem-cyclohexane sulfone based γ-secretase inhibitors for Alzheimer’s disease: Conformational analysis and biological activity
RA Jelley, J Elliott, KR Gibson, T Harrison, D Beher, EE Clarke, HD Lewis, ...
Bioorganic & medicinal chemistry letters 16 (14), 3839-3842, 2006
212006
In vitro and in vivo SAR of pyrido [3, 4-d] pyramid-4-ylamine based mGluR1 antagonists
SJ Mantell, KR Gibson, SA Osborne, GN Maw, H Rees, PG Dodd, ...
Bioorganic & medicinal chemistry letters 19 (8), 2190-2194, 2009
202009
Discovery of a first-in-class potent small molecule antagonist against the adrenomedullin-2 receptor
P Avgoustou, ABA Jailani, JO Zirimwabagabo, MJ Tozer, KR Gibson, ...
ACS pharmacology & translational science 3 (4), 706-719, 2020
172020
The system can't perform the operation now. Try again later.
Articles 1–20